260 related articles for article (PubMed ID: 2242614)
21. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
22. In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B.
Mondelli MU; Alberti A; Realdi G; Rondanelli EG
Int J Immunopharmacol; 1986; 8(8):887-91. PubMed ID: 3100465
[TBL] [Abstract][Full Text] [Related]
23. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
Appasamy R; Bryant J; Hassanein T; Van Thiel DH; Whiteside TL
Clin Immunol Immunopathol; 1994 Dec; 73(3):350-7. PubMed ID: 7955564
[TBL] [Abstract][Full Text] [Related]
24. Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
Panasiuk A; Prokopowicz D; Zak J
Hepatogastroenterology; 2004; 51(58):1088-92. PubMed ID: 15239252
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
[TBL] [Abstract][Full Text] [Related]
26. Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH).
Barnaba V; Levrero M; Franco A; Ruberti G; Musca A; Bonavita MS; Balsano F
Liver; 1986 Feb; 6(1):45-52. PubMed ID: 3487021
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.
Lu CL; Tsai ST; Chan CY; Hwang SJ; Tsai CY; Wu JC; Lu RH; Lin BC; Lee SD
J Gastroenterol Hepatol; 1997 Apr; 12(4):272-6. PubMed ID: 9195365
[TBL] [Abstract][Full Text] [Related]
28. HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease.
Freni MA; Ajello A; Resta ML; Gaeta GB; Spadaro A; Fava A; Calapristi I; Alessi N; Ferraù O
Eur J Clin Invest; 1991 Dec; 21(6):586-91. PubMed ID: 1723384
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
30. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
31. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
[TBL] [Abstract][Full Text] [Related]
32. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
Bruder Costa J; Dufeu-Duchesne T; Leroy V; Bertucci I; Bouvier-Alias M; Pouget N; Brevot-Lutton O; Bourliere M; Zoulim F; Plumas J; Aspord C;
PLoS One; 2016; 11(6):e0158297. PubMed ID: 27348813
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B.
Morimitsu Y; Kleiner DE; Conjeevaram HS; Hsia CC; Di Bisceglie AM; Tabor E
Hepatology; 1995 Oct; 22(4 Pt 1):1021-6. PubMed ID: 7557846
[TBL] [Abstract][Full Text] [Related]
34. Histologic changes in Chinese patients with chronic hepatitis B virus infection after interferon-alpha therapy.
Wu PC; Lok AS; Lau JY; Lauder IJ; Lai CL
Am J Clin Pathol; 1992 Oct; 98(4):402-7. PubMed ID: 1415022
[TBL] [Abstract][Full Text] [Related]
35. Immunological studies in patients with HBsAg-positive chronic active hepatitis--spontaneous lymphocyte transformation and natural killer cell activity.
Koo JY; Park BC; Chung JM
Korean J Intern Med; 1987 Jul; 2(2):221-6. PubMed ID: 3154834
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of lymphocyte phenotypes in HBV transgenic mice and the effect of interferon-α: a preliminary study].
Yan X; Zhong RH; Liu JH; Zhou Y; Tang LB; Li YY; Liu GZ; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):870-4. PubMed ID: 27320894
[TBL] [Abstract][Full Text] [Related]
37. Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment.
Lin Y; Shen G; Xie S; Bi X; Lu H; Yang L; Jiang T; Deng W; Wang S; Zhang L; Lu Y; Gao Y; Hao H; Wu S; Liu R; Chang M; Xu M; Hu L; Chen X; Huang R; Li M; Xie Y
Front Immunol; 2022; 13():1116160. PubMed ID: 36761161
[TBL] [Abstract][Full Text] [Related]
38. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.
Lucey MR; Graham DM; Martin P; Di Bisceglie A; Rosenthal S; Waggoner JG; Merion RM; Campbell DA; Nostrant TT; Appelman HD
Gut; 1992 Oct; 33(10):1390-6. PubMed ID: 1446866
[TBL] [Abstract][Full Text] [Related]
39. Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response.
Actis GC; Maran E; Bonino F; Saracco G; Rosina F; Brunetto MR; Baldi M; Rizzetto M; Verme G; Rocca B
J Biol Regul Homeost Agents; 1987; 1(1):45-50. PubMed ID: 2461050
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
